T1	Participants 72 111	patients with severe acute pancreatitis
T2	Participants 289 335	patients with severe acute pancreatitis (SAP).
T3	Participants 346 569	total of 71 patients with confirmed severe acute pancreatitis from March 2009 to September 2011 in the Department of Critical Care Medicine of Huizhou Municipal Central Hospital, Guangdong, China were enrolled in this study
T4	Participants 659 802	Patients were randomly assigned into 2 groups including a PCT-guided group (study group) and a prophylactic antibiotic therapy (control group).
T5	Participants 1735 1774	patients with severe acute pancreatitis
